22 results
Thumbnail

D1.259 - Healthcare interoperability: the promises and pitfalls relating to penicillin allergy delabelling

Thumbnail

D1.250 - Beyond the Label: A Multidisciplinary Effort to De-label Penicillin Allergy

Thumbnail

D1.251 - Documentation of drug allergy in the Electronic Health Record (EHR) at a Tertiary paediatric allergy service in the UK

Thumbnail

D1.252 - A model based economic evaluation to assess impact of Penicillin Allergy in COPD patients

Thumbnail

D1.253 - Comparison of Immune-Related Adverse Events in Patients Treated with Atezolizumab and Durvalumab: A Critical Concern for Clinical Management

Thumbnail

D1.254 - Assessing the Accuracy of Penicillin Allergy Labels in Paediatric Care: Focusing on Educational Gaps in Both Families and Healthcare Workers

Thumbnail

D1.255 - Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q): A Cross-Cultural Adaptation and Reliability Study

Thumbnail

D1.256 - Development of multiple drug hypersensitivity after DRESS syndrome induced by piperacillin/tazobactam

Thumbnail

D1.257 - Extensive allergological workup in the management of immediate adverse drug reactions to chemotherapy- a single centre experience

Thumbnail

D1.258 - Comparison of the Negative Predictive Values of One-Day and Five-Day Drug Provocation Tests in Late-Mild and Cutaneous Beta-Lactam Allergies in Children

Thumbnail

D1.260 - Hypersensitivity to Iodinated Contrast Media: Diagnostic Evaluation and Re-exposure Outcomes

Thumbnail

D1.248 - Perioperative hypersensitivity reaction (POH) with tranexamic acid: study of 2 cases

Thumbnail

D1.249 - Improving inpatient antimicrobial stewardship through single dose oral amoxicillin challenge among penicillin allergic veterans

Thumbnail

D1.149 - Murine IgG1 increased y subcutaneous immunotherapy suppressed development of allergic asthma

Thumbnail

D1.150 - Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)

Thumbnail

D1.152 - Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units

Thumbnail

D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites

Thumbnail

D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix

Thumbnail

D1.155 - Alterations in B cell memory induced by house dust mite allergen immunotherapy

Thumbnail

D1.156 - Early Immunologic Parameters Predicting Response to Sublingual Immunotherapy in Allergic Rhinitis Patients